The following video is part of our "Motley Fool Conversations" series, in which, David Williamson, health-care editor and analyst and Brendan Byrnes, industrials editor and analyst, discuss topics across the investing world.

In today's edition, David and Brendan discuss some of the worst health-care stocks of 2011. These stocks fit relatively neatly into three catagories: failure to launch, trial troubles, and home health-care scare. This video focuses on trial troubles, i.e., companies with promising drug candidates that either have struggled acing clinical trials or getting past the FDA gatekeepers. They also discuss which of the downtrodden stocks have brighter days ahead in 2012.

David Williamson and Brendan Byrnes do not own shares of the companies listed above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.